Kittleson MD, Meurs KM, Munro MJ, et al. Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation 1999;99:3172–3180.
Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease. Circulation 1995;92:2645–2651.
Meurs KM, Sanchez X, David RM, et al. A cardiac myosin binding protein c mutation in the maine coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 2005;14:3587–3593.
Meurs KM, Norgard MM, Ederer MM, et al. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 2007;90:261–264.
Stauffer BL, Konhilas JP, Luczak ED, et al. Soy diet worsens heart disease in mice. J Clin Invest 2006;116:209–216.
Tatsuguchi M, Hiratsuka E, Machida S, et al. Swimming exercise in infancy has beneficial effect on the hearts in cardiomyopathic Syrian hamsters. J Muscle Res Cell Motil 2004;25:69–76.
Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005;111:1999–2012.
Li X, Li S, Ulusoy E, et al. Childhood adiposity as a predictor of cardiac mass in adulthood. Circulation 2004;110:3488–3492.
Singhal A, Cole TJ, Fewtrell M, et al. Is slower early growth beneficial for long-term cardiovascular health? Circulation 2004;109:1108–1113.
Singhal A, Cole TJ, Fewtrell M, et al. Promotion of faster weight gain in infants born small for gestational age. Is there an adverse effect on later blood pressure? Circulation 2007;115:213–220.
Strauss RS, Dietz WH. Growth and development of term children born with low birth weight: effects of genetic and environmental factors. J Pediatr 1998;133:67–72.
Vonnahme KA, Hess BW, Hansen TR, et al. Maternal undernutrition from early-to mid-gestation leads to growth retardation, cardiac ventricular hypertrophy, and increased liver weight in the fetal sheep. Biol Reprod 2003;69:113–140.
Dong F, Ford SP, Fang CX, et al. Maternal nutrient restriction during early to mid gestation up-regulated cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep. Growth Horm IGF Res 2005;15:291–299.
Han HC, Austin KJ, Nathanielsz PW, et al. Maternal nutrient restriction alters gene expression in the ovine fetal heart. J Physiol 2004;558:111–121.
Kingdom JC, McQueen J, Connell JM, et al. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1993;100:476–482.
Kittleson MD, Pion PD, DeLellis LA, et al. Increased serum growth hormone concentration in feline hypertrophic cardiomyopathy. J Vet Intern Med 1992;6:320–324.
Hwang KJ, Lee KH. The effect of obesity and nutrient intake on serum IGF-1 and serotonin levels in school children. Korean J Nutr 2002;35:524–530.
Buchanan JW, Büecheler J. Vertebral scale system to measure canine heart size in radiographs. J Am Vet Med Assoc 1995;206:194–214.
Litster AL, Buchanan JW. Vertebral scale system to measure heart size in radiographs of cats. J Am Vet Med Assoc 2000;216:210–214.
Baty CJ, Malarkey DE, Atkins CE, et al. Natural history of hypertrophic cardiomyopathy and aortic thromboembolism in a family of domestic shorthair cats. J Vet Intern Med 2001;15:595–599.
Rush JE, Freeman LM, Fenollosa NK, et al. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc 2002;220:202–207.
Laflamme D. Development and validation of a body condition score system for cats: a clinical tool. Feline Pract 1997;25(5–6):13–18.
Lund EM, Armstrong PJ, Kirk CA, et al. Prevalence and risk factors for obesity in adult dogs from private US veterinary practices. Intern J Appl Res Vet Med 2006;4:177–186.
Scarlett JM, Donoghue S, Saidla J, et al. Overweight cats: prevalence and risk factors. Int J Obes Relat Metab Disord 1994;18:S22–S28.
Bunn RC, King WD, Winkler MK, et al. Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children. Pediatr Res 2005;58:89–93.
Advertisement
Objective—To compare morphometric measurements and serum insulin-like growth factor (IGF-1) concentration in cats with and without hypertrophic cardiomyopathy (HCM), and assess the hypothesis that cats with HCM have larger body size and skeletal features and higher serum IGF-1 concentrations than healthy cats.
Animals—25 cats with HCM and 22 healthy control cats.
Procedures—Physical examination and echocardiography were performed to classify cats into the HCM and control groups. Data collected from each cat included diet history, body weight, body condition score, lengths of the humerus and 4th and 12th thoracic vertebrae, heart size, head length and width, and abdominal circumferences. Comparisons of these variables were made between groups.
Results—Body condition score in HCM-affected and control cats did not differ significantly. However, median head width; lengths of the head, 4th and 12th thoracic vertebrae, and humerus; and body weight in the HCM-affected group were significantly greater than values in the control group. Median serum concentration of IGF-1 was not significantly different between groups.
Conclusions and Clinical Relevance—These data suggested that among the study cats, those with HCM were skeletally larger, but not more obese, than healthy cats. Whether this was attributable to differences in early growth or other causes requires additional investigation.
Supported by Boehringer Ingelheim Animal Health and the Barkley Fund.
Presented in abstract form at the American College of Veterinary Internal Medicine Forum, Seattle, June 2007.